Project
ICL670, Deferasirox
Completed ยท 2017 until 2020
Semela David, Stillhard Roman
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2017
End Date
2020
Financing
Industry
Brief description/objective
A phase II, multicenter, open-label, randomized two-year study to evaluate the efficacy and safety of deferasirox film-coated tablet versus phlebotomy in patients with Hereditary Hemochromatosis